We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay

    Background

    Ovarian cancer is the most lethal gynecologic malignancy in women, and high-grade serous ovarian cancer (HGSOC) is the most common subtype....

    Joohyun Ryu, Kristin L. M. Boylan, ... Stefani N. Thomas in Clinical Proteomics
    Article Open access 03 January 2024
  2. The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis

    Aim

    Epithelial ovarian cancer (EOC) is the most ominous tumor of gynecological cancers due to its poor early detection rate and unfavorable prognosis....

    Yagmur Minareci, Naziye Ak, ... Samet Topuz in Molecular Biology Reports
    Article 15 April 2024
  3. The Role of the Human Microbiome in Epithelial Ovarian Cancer

    Ovarian cancer is the fifth-leading cause of cancer deaths among women due to the absence of available screening methods to identify early disease....
    Chapter 2024
  4. Insights into the Microbial Composition of Intratumoral, Reproductive Tract, and Gut Microbiota in Ovarian Cancer Patients

    According to the latest global cancer data, ovarian cancer is the deadliest among all gynecological malignant tumors and ranks fifth in terms of...
    Chapter 2024
  5. EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer

    This study examines the prognostic role and immunological relevance of EMP1 (epithelial membrane protein-1) in a pan-cancer analysis, with a focus on...

    Jun Zhang, **g Yang, ... Yindi Bao in Molecular Genetics and Genomics
    Article 14 May 2024
  6. Drug-Resistant Epithelial Ovarian Cancer: Current and Future Perspectives

    Epithelial ovarian cancer (EOC) is a complex disease with diverse histological subtypes, which, based on the aggressiveness and course of disease...
    Megha Mehrotra, Pratham Phadte, ... Pritha Ray in Cell and Molecular Biology of Ovarian Cancer
    Chapter 2024
  7. The emerging roles of miRNA-mediated autophagy in ovarian cancer

    Ovarian cancer is one of the common tumors of the female reproductive organs. It has a high mortality rate, is highly heterogeneous, and early...

    Yamin Ding, Xuan Huang, ... Rongbin Wei in Cell Death & Disease
    Article Open access 03 May 2024
  8. Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness

    In ovarian tumors, the omental microenvironment profoundly influences the behavior of cancer cells and sustains the acquisition of stem-like traits,...

    Chiara Battistini, Hilary A. Kenny, ... Ugo Cavallaro in Cell Death & Disease
    Article Open access 28 May 2024
  9. CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α

    Ovarian cancer is the most lethal malignancy among gynecologic cancers, and primary and secondary chemotherapy resistance is one of the important...

    Article Open access 09 January 2024
  10. STAT3 mediates ECM stiffness-dependent progression in ovarian cancer

    The treatment of ovarian cancer remains a medical challenge and its malignant progression is connected with obvious changes in both tissue and cell...

    Sun Chenchen, Qian Xueqian, ... Han Yangyang in Molecular and Cellular Biochemistry
    Article 16 April 2024
  11. XTP8 Promotes Ovarian Cancer Progression by Activating AKT/AMPK/mTOR Pathway to Regulate EMT

    Ovarian cancer (OC) ranks as the fifth leading cause of cancer-related death in women. The main contributors to the poor prognosis of ovarian cancer...

    Ruixue Zhao, **n Ning, ... Rong Ma in Cell Biochemistry and Biophysics
    Article Open access 13 March 2024
  12. ATP6V1B1 regulates ovarian cancer progression and cisplatin sensitivity through the mTOR/autophagy pathway

    Early detection and effective chemotherapy for ovarian cancer, a serious gynecological malignancy, require further progress. This study aimed to...

    Shien Mo, Tingji Liu, ... Yan Kuang in Molecular and Cellular Biochemistry
    Article Open access 12 May 2024
  13. VCAM-1 complements CA-125 in detecting recurrent ovarian cancer

    Background

    Close to three-quarters of ovarian cancer cases are frequently diagnosed at an advanced stage, with more than 70% of them failing to...

    ** Song, Lori J. Sokoll, ... Daniel W. Chan in Clinical Proteomics
    Article Open access 25 June 2023
  14. MATN2 overexpression suppresses tumor growth in ovarian cancer via PTEN/PI3K/AKT pathway

    The incidence rate of develo** ovarian cancer decreases over the years; however, mortality ranks top among malignancies of women, mainly metastasis...

    **gbo Liu, **g Zhang, ... Youguo Chen in Functional & Integrative Genomics
    Article 03 April 2024
  15. The senescent mesothelial matrix accentuates colonization by ovarian cancer cells

    Ovarian cancer is amongst the most morbid of gynecological malignancies due to its diagnosis at an advanced stage, a transcoelomic mode of...

    Bharat Vivan Thapa, Mallar Banerjee, ... Ramray Bhat in Cellular and Molecular Life Sciences
    Article Open access 03 December 2023
  16. Overexpression of MKRN2 Inhibits the Growth of Ovarian Cancer Cells

    Abstract

    Ovarian cancer has a high mortality with low five-year survival rates. The role of the E3 ligase Makorin ring finger protein 2 (MKRN2) in...

    F. Z. Jiang, Q. J. **a, ... Y. M. Zhang in Molecular Biology
    Article 19 June 2023
  17. Advances in application of circulating tumor DNA in ovarian cancer

    Ovarian cancer is the third most common gynecologic cancer worldwide and has the highest mortality rate among gynecologic cancers. Identifying timely...

    Ting **a, Chenyan Fang, Yaqing Chen in Functional & Integrative Genomics
    Article 21 July 2023
  18. MicroRNA-10a-5p-mediated downregulation of GATA6 inhibits tumor progression in ovarian cancer

    Ovarian cancer is the common cause of cancer-related death in women and is considered the most deadly gynecological cancer. It has been established...

    Feiying Gao, Qiang Wu, Dan Lu in Human Cell
    Article 28 September 2023
  19. MiR-590-5p promotes cisplatin resistance via targeting hMSH2 in ovarian cancer

    Objective

    The mechanisms of ovarian cancer generate chemotherapy resistance are still unclear. This study aimed to explore the role of microRNA...

    Bing Li, Xuejie Xu, ... Guoliang Zhang in Molecular Biology Reports
    Article 01 July 2023
  20. Tripartite-motif 3 represses ovarian cancer progression by downregulating lactate dehydrogenase A and inhibiting AKT signaling

    The E3 ubiquitin ligase Tripartite-motif 3 (TRIM3) is known to play a crucial role in tumor suppression in various tumors through different...

    Yu Cong, **n Cui, ... Xuemei Jia in Molecular and Cellular Biochemistry
    Article 17 February 2024
Did you find what you were looking for? Share feedback.